You may qualify for this study and be compensated up to $3,450
Study objective: testing a new drug sub-lingual drug for the treatment of depression.
What is depression? Depression is a mood disorder that causes persistent sadness and loss of interest. It affects how you feel, think and behave and can lead to various emotional and physical problems. In 2020, an estimated 21.0 million adults in the United States had at least one major depressive episode. This number represented 8.4% of all U.S. adults.
Next check-in date: November 29, 2022
Refer a friend and earn up to $100
For more information, contact our recruiters at (844) 246-8459
Share this study:
Complete the registration form and call us at 844-246-8459. Our recruiters will be happy to help you, and it will take 5 minutes of your time to know if you are eligible. Your information will be kept strictly confidential.